Provectus Biopharmaceuticals (PVCT) EBITDA (2010 - 2025)
Provectus Biopharmaceuticals' EBITDA was -$1.12 million in Q4 2025, compared with -$2.33 million a year earlier.
Powered by 
Analysis
Provectus Biopharmaceuticals (PVCT) EBITDA (2010 - 2025) Analysis & Trends
For FY2025, EBITDA at Provectus Biopharmaceuticals came in at -$5.29 million.
- In earlier years, EBITDA was -$4.53 million in FY2024, -$2.89 million in FY2023, -$3.42 million in FY2022 and -$4.66 million in FY2021.
- Quarterly EBITDA has moved between -$2.33 million (Q4 2024) and -$445,034 (Q1 2024) over five years.
- Per Business Quant data, PVCT's EBITDA in the three quarters before Q4 2025 was -$1.28 million (Q3 2025), -$1.8 million (Q2 2025) and -$1.1 million (Q1 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,166.82 Bn | 1,135.41 Bn | 19.71 Bn | 12.29 Bn |
| 2 | Johnson & Johnson | 644.52 Bn | 564.38 Bn | 17.30 Bn | 8.30 Bn |
| 3 | AbbVie | 501.88 Bn | 474.99 Bn | 12.70 Bn | 8.33 Bn |
| 4 | Merck | 358.72 Bn | 313.10 Bn | 12.21 Bn | 999.00 Mn |
| 5 | Novartis Ag | 302.27 Bn | 266.26 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 267.62 Bn | 241.31 Bn | 12.86 Bn | 5.09 Bn |
| 7 | Amgen | 241.67 Bn | 197.07 Bn | 7.24 Bn | 4.63 Bn |
| 8 | Gilead Sciences | 193.09 Bn | 167.28 Bn | 6.22 Bn | -9.70 Bn |
| 9 | Pfizer | 171.60 Bn | 118.24 Bn | 10.94 Bn | 5.89 Bn |
| 10 | Provectus Biopharmaceuticals | 21.01 Mn | 19.10 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | -1.12 Mn |
| Sep 30, 2025 | -1.28 Mn |
| Jun 30, 2025 | -1.80 Mn |
| Mar 31, 2025 | -1.10 Mn |
| Dec 31, 2024 | -2.33 Mn |
| Sep 30, 2024 | -953,498.00 |
| Jun 30, 2024 | -792,624.00 |
| Mar 31, 2024 | -445,034.00 |
| Dec 31, 2023 | -602,456.00 |
| Sep 30, 2023 | -711,918.00 |
| Jun 30, 2023 | -797,972.00 |
| Mar 31, 2023 | -779,983.00 |
| Dec 31, 2022 | -681,681.00 |
| Sep 30, 2022 | -663,369.00 |
| Jun 30, 2022 | -1.08 Mn |
| Mar 31, 2022 | -996,840.00 |
| Dec 31, 2021 | -1.22 Mn |
| Sep 30, 2021 | -1.04 Mn |
| Jun 30, 2021 | -1.22 Mn |
| Mar 31, 2021 | -1.18 Mn |
API Access
Provectus Biopharmaceuticals EBITDA API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda&ticker=PVCT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda", "ticker": "PVCT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda&ticker=PVCT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();